Jack Nathan Medical Corp.
JNH.V
TSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.84M | 3.94M | 3.89M | 4.01M | 3.64M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.84M | 3.94M | 3.89M | 4.01M | 3.64M |
| Cost of Revenue | 705.00K | 839.40K | 841.10K | 1.08M | 867.70K |
| Gross Profit | 3.14M | 3.10M | 3.05M | 2.93M | 2.77M |
| SG&A Expenses | 3.84M | 4.06M | 3.98M | 4.66M | 3.29M |
| Depreciation & Amortization | 233.90K | 242.20K | 243.40K | 226.70K | 155.30K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.78M | 5.14M | 5.06M | 5.90M | 4.32M |
| Operating Income | -931.00K | -1.20M | -1.17M | -1.89M | -679.10K |
| Income Before Tax | -1.32M | -1.70M | -1.43M | -2.27M | -1.51M |
| Income Tax Expenses | -- | -- | -14.50K | -596.90K | -- |
| Earnings from Continuing Operations | -1.32M | -1.70M | -1.42M | -1.67M | -1.51M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.32M | -1.70M | -1.42M | -1.67M | -1.51M |
| EBIT | -931.00K | -1.20M | -1.17M | -1.89M | -679.10K |
| EBITDA | -748.70K | -1.02M | -984.70K | -1.72M | -576.70K |
| EPS Basic | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| EPS Diluted | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| Average Basic Shares Outstanding | 87.10M | 87.10M | 87.10M | 87.11M | 85.49M |
| Average Diluted Shares Outstanding | 96.10M | 87.10M | 96.10M | 87.11M | 89.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
